| The dual role of iNOS in cancer F Vannini, K Kashfi, N Nath Redox biology 6, 334-343, 2015 | 543 | 2015 |
| Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function S Wang, N Nath, M Adlam, S Chellappan Oncogene 18 (23), 3501-3510, 1999 | 291 | 1999 |
| PAK5, a new brain-specific kinase, promotes neurite outgrowth in N1E-115 cells C Dan, N Nath, M Liberto, A Minden Molecular and cellular biology 22 (2), 567-577, 2002 | 218 | 2002 |
| Rb and prohibitin target distinct regions of E2F1 for repression and respond to different upstream signals S Wang, N Nath, G Fusaro, S Chellappan Molecular and cellular biology 19 (11), 7447-7460, 1999 | 218 | 1999 |
| Nitric oxide-donating aspirin inhibits β-catenin/T cell factor (TCF) signaling in SW480 colon cancer cells by disrupting the nuclear β-catenin–TCF association N Nath, K Kashfi, J Chen, B Rigas Proceedings of the National Academy of Sciences 100 (22), 12584-12589, 2003 | 168 | 2003 |
| Regulation of Rb and E2F by signal transduction cascades: divergent effects of JNK1 and p38 kinases S Wang, N Nath, A Minden, S Chellappan The EMBO journal, 1999 | 158 | 1999 |
| Hydrogen sulfide-releasing NSAIDs inhibit the growth of human cancer cells: a general property and evidence of a tissue type-independent effect M Chattopadhyay, R Kodela, N Nath, YM Dastagirzada, ... Biochemical pharmacology 83 (6), 715-722, 2012 | 152 | 2012 |
| Growth inhibition of human colon cancer cells by nitric oxide (NO)-donating aspirin is associated with cyclooxygenase-2 induction and β-catenin/T-cell factor signaling, nuclear … JL Williams, N Nath, J Chen, TR Hundley, J Gao, L Kopelovich, K Kashfi, ... Cancer research 63 (22), 7613-7618, 2003 | 152 | 2003 |
| Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo M Chattopadhyay, R Kodela, N Nath, A Barsegian, D Boring, K Kashfi Biochemical pharmacology 83 (6), 723-732, 2012 | 112 | 2012 |
| Macrophage reprogramming and cancer therapeutics: role of iNOS-derived NO K Kashfi, J Kannikal, N Nath Cells 10 (11), 3194, 2021 | 97 | 2021 |
| Regulation of neuron survival and death by p130 and associated chromatin modifiers DX Liu, N Nath, SP Chellappan, LA Greene Genes & development 19 (6), 719-732, 2005 | 96 | 2005 |
| Apoptotic and mitogenic stimuli inactivate Rb by differential utilization of p38 and cyclin-dependent kinases N Nath, S Wang, V Betts, E Knudsen, S Chellappan Oncogene 22 (38), 5986-5994, 2003 | 58 | 2003 |
| Metal oxides and their composites for the photoelectrode of dye sensitized solar cells JJ Lee, MM Rahman, S Sarker, NCD Nath, AJS Ahammad, JK Lee Advances in composite materials for medicine and nanotechnology 1, 181-210, 2011 | 48 | 2011 |
| Nitro-aspirin inhibits MCF-7 breast cancer cell growth: effects on COX-2 expression and Wnt/β-catenin/TCF-4 signaling N Nath, R Vassell, M Chattopadhyay, M Kogan, K Kashfi Biochemical pharmacology 78 (10), 1298-1304, 2009 | 47 | 2009 |
| JS-K; a nitric oxide-releasing prodrug, modulates β-catenin/TCF signaling in leukemic Jurkat cells: Evidence of an S-nitrosylated mechanism N Nath, M Chattopadhyay, L Pospishil, LZ Cieciura, S Goswami, R Kodela, ... Biochemical pharmacology 80 (11), 1641-1649, 2010 | 44 | 2010 |
| NO-donating aspirin inhibits the growth of leukemic Jurkat cells and modulates β-catenin expression N Nath, G Labaze, B Rigas, K Kashfi Biochemical and Biophysical Research Communications 326 (1), 93-99, 2004 | 41 | 2004 |
| Hydrogen sulfide-releasing naproxen suppresses colon cancer cell growth and inhibits NF-κB signaling R Kodela, N Nath, M Chattopadhyay, DE Nesbitt, CA Velázquez-Martínez, ... Drug design, development and therapy, 4873-4882, 2015 | 39 | 2015 |
| Plasmids of corynebacteria JK Deb, N Nath FEMS microbiology letters 175 (1), 11-20, 1999 | 37 | 1999 |
| Hydrogen sulfide-releasing aspirin modulates xenobiotic metabolizing enzymes in vitro and in vivo M Chattopadhyay, R Kodela, N Nath, CR Street, CA Velázquez-Martínez, ... Biochemical Pharmacology 83 (6), 733-740, 2012 | 35 | 2012 |
| Tumor associated macrophages and ‘NO’ N Nath, K Kashfi Biochemical Pharmacology 176, 113899, 2020 | 33 | 2020 |
Khosrow Kashfi, PhD, FRSC, FRSBCity University of New York School of MedicineBestätigte E-Mail-Adresse bei AvicennaPharmaceuticals.com
